Founded in 1974, ACIC has evolved into a full service pharmaceutical and fine chemical company providing specialized products and support to their clients. ACIC offers an extensive range of products on an exclusive basis from cGMP and FDA approved manufacturers. ACIC’s global network enables them to offer custom synthesis/fermentation, lab and, commercial scale batches, scale up and process optimization. Their Pharmaceutical Division has expanded their portfolio to include finished dosage manufacturing in cGMP and FDA approved manufacturing sites.

ACIC has aligned their network to facilitate access to leading-edge technologies and services throughout the pharmaceutical industry. For example; Lyophilization is a complex preservative process that has moved into the forefront in the pharmaceutical trade today. Using this technology, pharmaceutical manufacturers are able to increase quality control and reduce bioburden for their finished products. ACIC has the means to bring a variety of lyophilized injectables to market, manufactured in facilities utilizing state of the art equipment and processes.

Further enhancing ACIC’s ability to move products “from Molecule to Market”, ACIC is capable of providing complete CRO, Bio-Analytical and Regulatory Services. ACIC’s strength stems from an integrated approach to form the best submission strategy for product providing a seamless path From Molecule to Market. ACIC invites you to visit them online at www.acic.com.

Note: The listing of a product does not constitute an offer for sale and is simply a representative list of products. Should you not find a product listed here, please contact us for further information. Not all products are available for all markets. In the United States, patented products are strictly available for Research and Development purposes only as permitted under 35 U.S.C. § 271(e)(1). In Canada, patented products are strictly available for Research and Development purposes only as permitted under section 55.2(1) of the Patent Act (Canada).